Dusseldorf - Delayed Quote EUR

Eli Lilly and Co (LLY.DU)

667.20
-19.50
(-2.84%)
At close: 7:30:55 PM GMT+2
Advanced Chart
Loading Chart for LLY.DU
  • Previous Close 686.70
  • Open 676.90
  • Bid 665.70 x --
  • Ask 667.70 x --
  • Day's Range 667.20 - 683.60
  • 52 Week Range 618.00 - 885.40
  • Volume 0
  • Avg. Volume 12
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date Aug 7, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: LLY.DU

View More
View More

Performance Overview: LLY.DU

Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

LLY.DU
10.55%
S&P 500 (^GSPC)
0.08%

1-Year Return

LLY.DU
3.69%
S&P 500 (^GSPC)
12.74%

3-Year Return

LLY.DU
146.66%
S&P 500 (^GSPC)
46.29%

5-Year Return

LLY.DU
389.80%
S&P 500 (^GSPC)
108.74%

Compare To: LLY.DU

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

LLY.DU
Eli Lilly and Co
667.20
-2.84%
Mkt Cap EUR -
Industry Drug Manufacturers—General
AMG.MU
Amgen Inc
246.40
+5.73%
Mkt Cap EUR -
Industry Drug Manufacturers—General
MRK.MX
Merck & Co., Inc.
1,495.00
-5.24%
Mkt Cap MXN 3.754T
Industry Drug Manufacturers—General
PFEB.F
Pfizer Inc.
6.55
+3.15%
Mkt Cap EUR 116.443B
Industry Drug Manufacturers—General
REC.MI
Recordati Industria Chimica e Farmaceutica S.p.A.
51.75
+0.19%
Mkt Cap EUR 10.98B
Industry Drug Manufacturers—General
0QIU.IL
Novo Nordisk A/S
440.00
-0.29%
Mkt Cap DKK 1.848T
Industry Drug Manufacturers—General
GRFS
Grifols, S.A.
7.86
+1.68%
Mkt Cap 5.988B
Industry Drug Manufacturers—General
BAYRY
Bayer Aktiengesellschaft
6.93
+2.97%
Mkt Cap 27.254B
Industry Drug Manufacturers—General
NOV.DE
Novo Nordisk A/S
58.55
-2.06%
Mkt Cap EUR 257.484B
Industry Drug Manufacturers—General
AZN.L
AstraZeneca PLC
10,180.00
-0.90%
Mkt Cap GBp 164.386B
Industry Drug Manufacturers—General
SNY
Sanofi
49.96
-2.15%
Mkt Cap 124.737B
Industry Drug Manufacturers—General

Statistics: LLY.DU

View More

Valuation Measures

Annual
As of 5/12/2025

  • Market Cap

    604.07B

  • Enterprise Value

    635.51B

  • Trailing P/E

    62.74

  • Forward P/E

    35.34

  • PEG Ratio (5yr expected)

    1.18

  • Price/Sales (ttm)

    14.21

  • Price/Book (mrq)

    43.91

  • Enterprise Value/Revenue

    14.56

  • Enterprise Value/EBITDA

    43.85

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

View More

Research Analysis: LLY.DU

View More
View More

Company Insights: LLY.DU

Research Reports: LLY.DU

View More
View More

People Also Watch

LLY.MU Eli Lilly and Co
667.60
+4.41%
 
LLY.HM Eli Lilly and Co
671.30
-0.59%
 
LLY.HA Eli Lilly and Co
671.90
-0.53%
 
LLY.SG Eli Lilly and Co
667.50
-1.85%
 
LLY.BE Eli Lilly and Co
685.00
+7.37%
 
LLY.DE Eli Lilly and Company
672.10
-0.56%
 
CUP.F Chugai Pharmaceutical Co., Ltd.
45.17
-5.90%
 
4AB.F AbbVie Inc.
169.20
-0.70%
 
LLY.F Eli Lilly and Company
670.00
-2.15%
 
LILY34.SA Eli Lilly and Company
143.09
-0.22%
 
BRM.HM Bristol-Myers Squibb Co
41.86
-1.96%
 
AMG.DE Amgen Inc.
242.25
-1.62%
 
4AB.BE AbbVie Inc
168.60
-1.63%
 
003090.KS Daewoong Co., Ltd.
19,810.00
-2.41%
 
GIS.DE Gilead Sciences, Inc.
91.13
-1.58%
 
LLY.MX Eli Lilly and Company
14,506.04
-2.01%